Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

Blockchain networks face a quiet but serious problem that grows over time. As transactions pile up, nodes must store more ...

Health Discovery Corp. advanced stock charts by Barron's. View HDVY historical stock data and compare to other stocks, and exchanges.

Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...

The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

MIT’s Recursive Language Models rethink AI memory by treating documents like searchable environments, enabling models to ...

Along with just about every other monitor brand on planet earth, Gigabyte has unleashed a load of new OLED gaming displays at ...

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.

Nkembuh, N. (2026) Symbiotic Communication Systems: Examining the Co-Evolution of Human-AI Communication Patterns in the ...